FRANCIA, Ada
 Distribuzione geografica
Continente #
NA - Nord America 3.366
EU - Europa 944
AS - Asia 628
SA - Sud America 23
AF - Africa 6
Totale 4.967
Nazione #
US - Stati Uniti d'America 3.335
IT - Italia 295
SG - Singapore 277
SE - Svezia 230
IN - India 184
CN - Cina 139
UA - Ucraina 95
FI - Finlandia 87
DE - Germania 73
GB - Regno Unito 32
IE - Irlanda 30
BG - Bulgaria 28
CA - Canada 27
AT - Austria 22
AR - Argentina 19
RO - Romania 17
ID - Indonesia 11
BE - Belgio 9
FR - Francia 7
TG - Togo 6
HK - Hong Kong 4
MX - Messico 4
BR - Brasile 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
NL - Olanda 3
AL - Albania 2
BH - Bahrain 2
ES - Italia 2
LT - Lituania 2
TR - Turchia 2
CL - Cile 1
HR - Croazia 1
IL - Israele 1
JP - Giappone 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 4.967
Città #
Fairfield 548
Chandler 274
Woodbridge 272
Ashburn 268
Singapore 214
Houston 191
Cambridge 168
Ann Arbor 167
Seattle 158
Wilmington 156
Rome 137
Dearborn 96
Princeton 94
Plano 82
Beijing 74
Santa Clara 59
Lawrence 56
San Paolo di Civitate 54
Boston 46
Jacksonville 38
Millbury 38
San Diego 31
Dublin 30
Sofia 28
Andover 26
Norwalk 26
Munich 21
Federal 19
Helsinki 19
Vienna 19
Des Moines 14
Fremont 14
Hefei 14
Toronto 13
Ottawa 12
Jakarta 11
Boardman 10
San Mateo 10
Brussels 9
Venezia 9
Falkenstein 7
Falls Church 7
New York 7
Bühl 6
Kunming 6
Lomé 6
Milan 6
Nanjing 6
Phoenix 6
Bremen 5
Jinan 5
Laurel 5
Mannheim 5
Nanchang 5
Fasano 4
Foligno 4
Hong Kong 4
London 4
Redmond 4
Amsterdam 3
Atlanta 3
Brno 3
Dallas 3
Fuzhou 3
Genova 3
Guangzhou 3
Hyderabad 3
Pune 3
San Jose 3
Auburn Hills 2
Bari 2
Bern 2
Birmingham 2
Buffalo 2
Cincinnati 2
Fortaleza 2
Genzano 2
Gunzenhausen 2
Indiana 2
Manama 2
Mexico City 2
Padova 2
Paris 2
Pomezia 2
Saint Louis 2
Shanghai 2
Sherbrooke 2
Taranto 2
Terni 2
Trumbull 2
Wuhan 2
Aversa 1
Bad Bellingen 1
Bangkok 1
Bielefeld 1
Bishkek 1
Bratislava 1
Changsha 1
Chengdu 1
Chicago 1
Totale 3.710
Nome #
fMRI pain activation in the periaqueductal gray in healthy volunteers during the cold pressor test. 131
A female with central anticholinergic syndrome responsive to neostigmine 126
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis 108
Role of brain perfusion SPECT with 99mTc HMPAO in the assessment of response to drug therapy in patients with autoimmune vasculitis: a prospective study 98
Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases 98
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 94
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment 89
Life-threatening intracranial hypotension after diagnostic lumbar puncture 88
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. 86
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study 83
Peripheral blood biomarkers in multiple sclerosis. 82
From high- to low-frequency administered interferon-beta for multiple sclerosis: A multicenter study 80
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 79
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 79
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 78
Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease 78
A study of spontaneous motility (“General Movements”) to assess psychomotor development in offspring of epileptic mothers on anticonvulsant drug treatment during pregnancy. 78
MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters 77
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study. 77
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial 77
Psychomotor development and general movements in offspring of women with epilepsy and anticonvulsant therapy 76
99mTc-HMPAO brain SPECT in the monitoring of cerebral vasculitis therapy 76
Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13 76
Systemic sclerosis and multiple sclerosis 74
Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation 73
Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p 73
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 73
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 72
Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. 70
H-magnetic resonance spectroscopy. diagnostic tool in recurrent headache in systemic lupus erythematosus. a case report 70
Multi-domain cognitive impairment disclosed before the diagnosis of chronic lymphocytic leukaemia: an autoimmune/paraneoplastic disorder? 69
The 677C-T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus 68
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus 64
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 64
Seizures in Alzheimer's disease: a retrospective study of a cohort of outpatients. 63
MRI in the study of distal primary myopathies and of muscular alterations due to peripheral neuropathies: Possible diagnostic capacities of MR equipment with low intensity field (0.2 T) dedicated to peripheral limbs 62
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). 62
Structural brain MR imaging changes associated with obsessive-compulsive disorder in patients with multiple sclerosis. 62
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP. 61
Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. 61
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 61
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 61
Botulism: A case associated with pyramidal signs 60
Influence of inherited and acquired thrombophilic defects on the clinical manifestations of mixed cryoglobulinemy 59
Scleroderma and motor neuron disease: An unusual association 59
Assesment of emotional responses in patient affected by epilepsy: adaptive and disadaptive aspects 57
null 57
null 56
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial. 56
null 56
NMR-based metabolomics approach to study urines of chronic inflammatory rheumatic diseases patients. 54
CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment. 54
Analisi molecolare della regione genomica di controllo della trascrizione genica del Polyomavirus umano JC in pazienti trattati con farmaci biologici: dati preliminari di uno studio longitudinale. 53
Heart rate variability and familial amyloidosis 52
Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study 50
null 50
CLINICAL SIGNS AND SERIAL MRI IN LISTERIA RHOMBOENCEPHALITIS: A CASE REPORT. 49
null 49
Human Polyomavirus JC monitoring and CD49d expression in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study. 46
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 46
Aspetti psicopatologici in pazienti epilettici: studio di una casistica ambulatoriale nel periodo 1994-1998 43
Can immune disorders influence therapeutic approaches in treatment of epilepsy among neurologists? A first cooperative national recognition in Italy 43
A 6-MONTH RANDOMIZED CONTROLLED TRIAL OF INTRAVENOUS IMMUNOGLOBULINS VERSUS INTRAVENOUSMETHYLPREDNISOLONE IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (IMC STUDY) 42
Wernicke encephalopathy: a case report 41
Human Polyomavirus JC monitoring in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study 41
Polyomavirus JC monitoring and regulatory region analysis in dynamic cohorts of immune-mediated diseases treated with biologics: an observational study. 40
Studio della motilità spontanea (“General Movements”) per la valutazione dello sviluppo psicomotorio nei nati da pazienti epilettiche in trattamento con farmaci anticonvulsivanti(AED) durante la gravidanza 39
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by multiple sclerosis under treatment with natalizumab: an observational study 39
Analysis of polyomavirus JC noncoding control region rearrangements in autoimmune diseases during treatment with natalizumab and anti-TNF agents 39
can immine disorders inflluence therapeutic approaches therapeutic approaches in treatment of epilepsy among neurologists? A first cooperative national recognition in Italy 36
Chronic Cerebro-Spinal Venous Insufficiency is not significantly associated to Relapsing-Remitting Multiple Sclerosis. 35
Neurological Involvement in Primary Sjogren Syndrome: A Focus on Central Nervous System 35
Wernicke encephalopathy: a case report. 34
Role of 99mTc-HMPAO brain perfusion SPECT in the clinical management of autoimmune brain vasculitis. 34
Assesment of emotional responses in patient affected by epilepsy: adaptive and disadaptive aspects. 33
Aspetti psicopatologici in pazienti epilettici: studio di una casistica ambulatoriale nel periodo 1994-1998 32
null 31
Valutazione delle risposte emozionali di pazienti affetti da epilessia. Aspetti adattativi e Disadattativi 31
Screening of microvascular endothelial cDNA library identifies rabaptin 5 as a novel autoantigen in Alzeimer’s disease. 30
null 28
Studio della motilità spontanea (“General Movements”) per la valutazione dello sviluppo psicomotorio nei nati da pazienti epilettiche in trattamento con farmaci anticonvulsivanti (AED) durante la gravidanza. 25
Cognitive fatigue in multiple sclerosis: an fMRI study 23
Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection 23
Olanzapine-induced neutropenia in a patient with systemic lupus erythematosus: a role of Fc gamma RIIIb polymorphism? 23
Choroidal Fissure Cysts and temporal lobe epilepsy 21
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 21
Intracranial hemodynamic changes in primary Sjögren syndrome: a transcranial Doppler case-control study. 14
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 14
Intradetrusorial botulinum toxin in patients with multiple sclerosis: A neurophysiological study 13
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 13
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 12
Totale 5.168
Categoria #
all - tutte 14.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020998 0 0 0 0 125 181 194 157 124 122 53 42
2020/2021346 34 58 9 17 6 27 14 26 49 65 35 6
2021/2022890 9 56 84 23 114 34 5 85 63 65 179 173
2022/2023963 178 190 75 92 110 96 34 43 81 13 35 16
2023/2024347 23 51 12 35 22 43 9 26 0 58 33 35
2024/2025396 39 169 43 38 107 0 0 0 0 0 0 0
Totale 5.168